IIM
FENC icon

INTECH Investment Management’s Fennec Pharmaceuticals FENC Stock Holding History

INTECH Investment Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,452
Closed -$80.5K – 2195
2025
Q4 		$80.5K Sell
10,452
-932
-8% -$7.65K ﹤0.01% 2195
2025
Q3 		$107K Sell
11,384
-579
-5% -$5.01K ﹤0.01% 2240
2025
Q2 		$99.3K Sell
11,963
-3,165
-21% -$21.6K ﹤0.01% 2297
2025
Q1 		$92.1K Buy
15,128
+4,140
+38% +$26.6K ﹤0.01% 2332
2024
Q4 		$69.4K Buy
+10,988
New +$56.3K ﹤0.01% 2281

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Potomac Capital Management New York $147M AUM

INTECH Investment Management's FENC Position: Q1 2026 in Review

INTECH Investment Management sold out of Fennec Pharmaceuticals (FENC) in Q1 2026, closing a stake of 10,452 shares — an estimated $80.5K sold.

INTECH Investment Management first reported a position in FENC in Q4 2024 and held it in 5 quarters. The position peaked at $107K in Q3 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • INTECH Investment Management reported no remaining Fennec Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • INTECH Investment Management sold 10,452 Fennec Pharmaceuticals shares in Q1 2026, an estimated $80.5K.
  • INTECH Investment Management first reported a position in Fennec Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • INTECH Investment Management's Fennec Pharmaceuticals position peaked at $107K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.